Healthcare Sector Stocks
The Healthcare sector has a total of 1060 stocks, with a combined market cap of $9.27 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.55.
Market Cap
9.27T
Revenue
4.66T
Profits
187.03B
PE Ratio
49.55
Profit Margin
4.01%
Dividend Yield
0.38%
1060 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.08T | -0.92% | 1,927,273 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 631.59B | 0.47% | 4,852,714 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 443.23B | 0.83% | 4,370,407 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 358.19B | -1.61% | 4,170,216 | 450.53B |
| 5 | MRK | Merck & Co., Inc. | 334.43B | 1.98% | 8,895,212 | 66.57B |
| 6 | NVS | Novartis AG | 289.45B | -0.39% | 1,517,179 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 245.10B | -0.79% | 3,598,337 | 61.37B |
| 8 | AMGN | Amgen Inc. | 225.90B | 0.40% | 2,778,005 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 220.33B | -1.18% | 1,448,334 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 203.52B | 0.71% | 10,186,917 | 50.34B |
| 11 | ABT | Abbott Laboratories | 192.54B | 0.32% | 5,523,720 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 171.29B | 1.67% | 4,897,035 | 30.46B |
| 13 | PFE | Pfizer Inc. | 152.75B | 1.86% | 35,355,834 | 63.70B |
| 14 | DHR | Danaher Corporation | 143.33B | -0.92% | 1,920,400 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 141.76B | - | 2,355,575 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 132.06B | 1.49% | 10,526,098 | 49.19B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 130.90B | -1.77% | 863,530 | 12.59B |
| 18 | SYK | Stryker Corporation | 130.83B | -1.76% | 2,017,200 | 25.84B |
| 19 | CVS | CVS Health Corporation | 121.49B | 0.29% | 6,493,250 | 412.65B |
| 20 | MDT | Medtronic plc | 115.95B | -0.20% | 6,475,826 | 36.36B |
| 21 | SNY | Sanofi | 105.64B | 0.16% | 2,213,791 | 55.89B |
| 22 | GSK | GSK plc | 100.41B | 0.30% | 2,692,536 | 44.05B |
| 23 | MCK | McKesson Corporation | 99.88B | -2.51% | 992,495 | 410.98B |
| 24 | HCA | HCA Healthcare, Inc. | 89.14B | -0.69% | 1,079,849 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 86.36B | -0.23% | 652,286 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 80.48B | 1.00% | 709,747 | 15.53B |
| 27 | BSX | Boston Scientific Corporation | 74.91B | 0.53% | 15,699,990 | 21.00B |
| 28 | CI | The Cigna Group | 73.46B | 0.21% | 1,400,043 | 282.38B |
| 29 | COR | Cencora, Inc. | 59.16B | -1.32% | 1,542,853 | 332.77B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 56.22B | -0.11% | 1,953,295 | 28.42B |
| 31 | ARGX | argenx SE | 54.43B | -2.18% | 171,353 | 5.32B |
| 32 | CAH | Cardinal Health, Inc. | 53.78B | -1.25% | 2,845,420 | 254.25B |
| 33 | EW | Edwards Lifesciences Corporation | 53.35B | -0.53% | 2,809,926 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 49.57B | -0.88% | 2,155,407 | 22.48B |
| 35 | MDLN | Medline Inc. | 46.78B | 0.23% | 6,955,203 | 29.94B |
| 36 | HUM | Humana Inc. | 46.23B | -0.99% | 754,150 | 145.68B |
| 37 | NTRA | Natera, Inc. | 44.80B | -1.64% | 1,522,101 | 2.71B |
| 38 | IDXX | IDEXX Laboratories, Inc. | 44.66B | -0.64% | 511,607 | 4.55B |
| 39 | RVMD | Revolution Medicines, Inc. | 43.30B | -1.59% | 986,763 | - |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 42.56B | -0.60% | 7,608,871 | 17.32B |
| 41 | HLN | Haleon plc | 42.55B | - | 5,420,868 | 14.80B |
| 42 | A | Agilent Technologies, Inc. | 42.16B | 0.71% | 1,026,820 | 7.23B |
| 43 | VEEV | Veeva Systems Inc. | 41.04B | 4.61% | 2,590,635 | 3.32B |
| 44 | WAT | Waters Corporation | 40.63B | -0.63% | 688,565 | 4.64B |
| 45 | ONC | BeOne Medicines AG | 40.48B | -0.85% | 355,459 | 6.13B |
| 46 | IQV | IQVIA Holdings Inc. | 39.75B | -0.08% | 749,802 | 16.98B |
| 47 | ALC | Alcon Inc. | 35.39B | -0.08% | 1,727,555 | 10.86B |
| 48 | DXCM | DexCom, Inc. | 34.52B | 0.75% | 4,686,458 | 4.97B |
| 49 | RPRX | Royalty Pharma plc | 33.67B | -1.11% | 2,516,785 | 2.54B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 33.33B | 2.09% | 2,278,401 | 21.27B |
| 51 | RMD | ResMed Inc. | 32.71B | 0.33% | 1,167,600 | 5.65B |
| 52 | CNC | Centene Corporation | 32.62B | -1.54% | 3,538,533 | 180.30B |
| 53 | ZTS | Zoetis Inc. | 31.34B | 3.13% | 7,351,641 | 9.53B |
| 54 | BIIB | Biogen Inc. | 31.12B | 0.85% | 860,095 | 10.03B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 30.39B | 1.42% | 1,449,424 | 4.80B |
| 56 | ILMN | Illumina, Inc. | 29.09B | -0.14% | 1,061,432 | 4.49B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.67B | -0.54% | 89,591 | 4.13B |
| 58 | INSM | Insmed Incorporated | 27.59B | -4.50% | 2,479,563 | 1.14B |
| 59 | PHG | Koninklijke Philips N.V. | 26.71B | 2.16% | 836,518 | 20.18B |
| 60 | ROIV | Roivant Sciences Ltd. | 26.21B | 0.33% | 6,028,111 | 7.53M |
| 61 | LH | Labcorp Holdings Inc. | 26.16B | -0.28% | 352,502 | 14.35B |
| 62 | DGX | Quest Diagnostics Incorporated | 26.05B | -0.73% | 549,034 | 11.56B |
| 63 | MRNA | Moderna, Inc. | 25.41B | -0.03% | 8,159,738 | 2.23B |
| 64 | INCY | Incyte Corporation | 24.43B | -0.21% | 829,464 | 5.82B |
| 65 | WST | West Pharmaceutical Services, Inc. | 24.36B | -1.74% | 777,640 | 3.33B |
| 66 | BNTX | BioNTech SE | 23.14B | -0.67% | 988,541 | 3.03B |
| 67 | STE | STERIS plc | 23.02B | -0.22% | 566,124 | 6.04B |
| 68 | THC | Tenet Healthcare Corporation | 21.50B | 0.10% | 778,159 | 21.81B |
| 69 | UTHR | United Therapeutics Corporation | 21.50B | -2.04% | 408,060 | 3.15B |
| 70 | GH | Guardant Health, Inc. | 21.41B | -3.37% | 2,800,255 | 1.18B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 18.99B | 1.72% | 2,619,386 | 8.51B |
| 72 | GMAB | Genmab A/S | 18.65B | -0.25% | 4,094,878 | 4.13B |
| 73 | VTRS | Viatris Inc. | 18.42B | -0.37% | 16,157,285 | 14.74B |
| 74 | MEDP | Medpace Holdings, Inc. | 16.24B | -2.52% | 151,062 | 2.78B |
| 75 | ASND | Ascendis Pharma A/S | 16.23B | -3.61% | 1,060,638 | 1.20B |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 15.96B | -1.25% | 468,026 | 4.60B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 15.88B | -3.14% | 1,279,658 | 713.07M |
| 78 | NBIX | Neurocrine Biosciences, Inc. | 15.33B | -3.62% | 2,055,842 | 3.37B |
| 79 | COO | The Cooper Companies, Inc. | 14.94B | -0.17% | 1,387,549 | 4.23B |
| 80 | SOLV | Solventum Corporation | 14.72B | 1.37% | 1,232,090 | 8.31B |
| 81 | BAX | Baxter International Inc. | 13.98B | 0.37% | 6,711,519 | 11.47B |
| 82 | CRL | Charles River Laboratories International, Inc. | 13.43B | -1.09% | 1,054,964 | 4.00B |
| 83 | BMRN | BioMarin Pharmaceutical Inc. | 13.27B | -2.43% | 2,317,020 | 3.41B |
| 84 | RVTY | Revvity, Inc. | 13.11B | -0.32% | 1,373,247 | 2.91B |
| 85 | ICLR | ICON Public Limited Company | 12.92B | 0.19% | 442,064 | 8.29B |
| 86 | PEN | Penumbra, Inc. | 12.87B | 0.05% | 209,553 | 1.50B |
| 87 | SNN | Smith & Nephew plc | 12.55B | 0.90% | 979,735 | 6.30B |
| 88 | BTSG | BrightSpring Health Services, Inc. | 12.55B | 0.92% | 1,372,749 | 14.37B |
| 89 | EXEL | Exelixis, Inc. | 12.54B | 0.46% | 1,948,741 | 2.44B |
| 90 | FMS | Fresenius Medical Care AG | 12.53B | -0.38% | 508,867 | 22.19B |
| 91 | ALGN | Align Technology, Inc. | 12.52B | 1.25% | 541,592 | 4.14B |
| 92 | EHC | Encompass Health Corporation | 12.19B | -1.03% | 549,274 | 6.21B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.09B | -1.90% | 1,101,912 | 669.50M |
| 94 | CORT | Corcept Therapeutics Incorporated | 11.95B | -1.49% | 740,456 | 830.81M |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.72B | -5.38% | 277,892 | 1.28B |
| 96 | GMED | Globus Medical, Inc. | 11.54B | 0.32% | 1,385,750 | 3.14B |
| 97 | DVA | DaVita Inc. | 11.43B | -1.28% | 655,541 | 14.01B |
| 98 | HALO | Halozyme Therapeutics, Inc. | 11.43B | -1.10% | 1,982,781 | 1.66B |
| 99 | ELAN | Elanco Animal Health Incorporated | 11.25B | 1.72% | 5,574,096 | 5.02B |
| 100 | TECH | Bio-Techne Corporation | 11.25B | -0.08% | 1,976,173 | 1.22B |
| 101 | AXSM | Axsome Therapeutics, Inc. | 11.19B | -0.46% | 705,315 | 776.57M |
| 102 | GKOS | Glaukos Corporation | 11.17B | 1.51% | 762,150 | 612.84M |
| 103 | SMMT | Summit Therapeutics Inc. | 11.17B | -7.28% | 6,562,459 | - |
| 104 | MOH | Molina Healthcare, Inc. | 10.72B | -0.17% | 675,198 | 42.47B |
| 105 | ABVX | ABIVAX Société Anonyme | 10.60B | -3.24% | 812,802 | 5.67M |
| 106 | RDY | Dr. Reddy's Laboratories Limited | 10.53B | 0.24% | 2,802,863 | 3.50B |
| 107 | ENSG | The Ensign Group, Inc. | 10.51B | 0.14% | 423,169 | 5.49B |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 10.29B | -4.63% | 274,233 | 7.46M |
| 109 | CYTK | Cytokinetics, Incorporated | 10.21B | -2.90% | 1,771,363 | 67.67M |
| 110 | PODD | Insulet Corporation | 10.16B | 0.95% | 1,368,508 | 3.05B |
| 111 | APGE | Apogee Therapeutics, Inc. | 10.14B | -0.07% | 1,257,000 | - |
| 112 | UHS | Universal Health Services, Inc. | 10.09B | -0.72% | 761,166 | 18.11B |
| 113 | HSIC | Henry Schein, Inc. | 10.04B | -0.68% | 960,952 | 13.60B |
| 114 | PTGX | Protagonist Therapeutics, Inc. | 9.80B | -0.39% | 444,786 | 281.99M |
| 115 | TEM | Tempus AI, Inc. | 9.80B | -0.59% | 2,256,369 | 1.43B |
| 116 | KRYS | Krystal Biotech, Inc. | 9.72B | -1.36% | 135,629 | 440.48M |
| 117 | BIO | Bio-Rad Laboratories, Inc. | 9.66B | -0.25% | 207,471 | 2.59B |
| 118 | KYMR | Kymera Therapeutics, Inc. | 9.51B | 0.34% | 481,718 | 105.00M |
| 119 | OSCR | Oscar Health, Inc. | 9.49B | 3.95% | 5,404,846 | 15.32B |
| 120 | RGEN | Repligen Corporation | 9.45B | 1.08% | 762,300 | 785.10M |
| 121 | AVTR | Avantor, Inc. | 9.37B | -0.57% | 5,935,599 | 6.56B |
| 122 | IONS | Ionis Pharmaceuticals, Inc. | 9.28B | -1.17% | 1,220,460 | 874.09M |
| 123 | SYRE | Spyre Therapeutics, Inc. | 8.98B | -2.15% | 525,435 | - |
| 124 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.96B | -0.02% | 1,289,232 | 42.16M |
| 125 | QGEN | Qiagen N.V. | 8.94B | 0.53% | 3,178,341 | 2.10B |
| 126 | HQY | HealthEquity, Inc. | 8.83B | 0.09% | 893,761 | 1.34B |
| 127 | BRKR | Bruker Corporation | 8.83B | -2.26% | 1,747,978 | 3.50B |
| 128 | PCVX | Vaxcyte, Inc. | 8.76B | -1.32% | 839,078 | - |
| 129 | IMVT | Immunovant, Inc. | 8.64B | -1.83% | 1,361,091 | - |
| 130 | ATR | AptarGroup, Inc. | 8.43B | -0.44% | 490,791 | 3.93B |
| 131 | ALKS | Alkermes plc | 8.30B | -1.65% | 1,546,633 | 1.67B |
| 132 | IBRX | ImmunityBio, Inc. | 8.11B | -1.16% | 6,006,747 | 165.79M |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.99B | -1.34% | 759,776 | 239.92M |
| 134 | TWST | Twist Bioscience Corporation | 7.86B | 0.06% | 912,214 | 431.80M |
| 135 | TXG | 10x Genomics, Inc. | 7.58B | 0.69% | 2,866,245 | 616.91M |
| 136 | ORKA | Oruka Therapeutics, Inc. | 7.16B | 0.67% | 719,457 | - |
| 137 | PACS | PACS Group, Inc. | 7.12B | -1.06% | 480,413 | 5.55B |
| 138 | HNGE | Hinge Health, Inc. | 7.05B | 1.27% | 798,132 | 720.06M |
| 139 | GRFS | Grifols, S.A. | 7.01B | - | 425,993 | 8.48B |
| 140 | CHE | Chemed Corporation | 6.99B | -0.71% | 233,454 | 2.60B |
| 141 | TGTX | TG Therapeutics, Inc. | 6.80B | -3.15% | 2,769,550 | 799.54M |
| 142 | HIMS | Hims & Hers Health, Inc. | 6.71B | -4.00% | 12,722,211 | 2.58B |
| 143 | CGON | CG Oncology, Inc. | 6.62B | -2.96% | 748,889 | 6.23M |
| 144 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.21% | 752,880 | 1.56B |
| 145 | BLTE | Belite Bio, Inc | 6.54B | -7.07% | 491,665 | - |
| 146 | COGT | Cogent Biosciences, Inc. | 6.48B | -4.28% | 1,414,241 | - |
| 147 | SRRK | Scholar Rock Holding Corporation | 6.46B | -1.41% | 942,959 | - |
| 148 | LQDA | Liquidia Corporation | 6.45B | -8.49% | 4,331,582 | 450.91M |
| 149 | MIRM | Mirum Pharmaceuticals, Inc. | 6.41B | -0.20% | 734,947 | 618.07M |
| 150 | CAI | Caris Life Sciences, Inc. | 6.27B | -0.36% | 2,972,665 | 989.61M |
| 151 | ERAS | Erasca, Inc. | 6.25B | -3.88% | 2,604,949 | - |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 6.22B | -1.58% | 496,373 | 7.50M |
| 153 | DNTH | Dianthus Therapeutics, Inc. | 6.13B | -2.50% | 411,052 | 1.90M |
| 154 | RDNT | RadNet, Inc. | 6.08B | 0.47% | 663,408 | 2.27B |
| 155 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.07B | -0.41% | 451,328 | 840.85M |
| 156 | BLCO | Bausch + Lomb Corporation | 6.06B | 1.31% | 410,469 | 5.32B |
| 157 | PTCT | PTC Therapeutics, Inc. | 6.01B | -0.92% | 697,348 | 1.01B |
| 158 | DFTX | Definium Therapeutics, Inc. | 5.90B | 2.59% | 2,664,396 | - |
| 159 | STVN | Stevanato Group S.p.A. | 5.88B | 1.27% | 571,496 | 1.40B |
| 160 | TFX | Teleflex Incorporated | 5.82B | 0.77% | 963,894 | 2.25B |
| 161 | TVTX | Travere Therapeutics, Inc. | 5.79B | -1.17% | 1,285,337 | 591.33M |
| 162 | LGND | Ligand Pharmaceuticals Incorporated | 5.76B | -1.52% | 255,440 | 290.54M |
| 163 | MMED | MiniMed Group, Inc. | 5.62B | -3.29% | 1,092,079 | 3.10B |
| 164 | AMRX | Amneal Pharmaceuticals, Inc. | 5.52B | -2.21% | 2,244,114 | 3.12B |
| 165 | SHC | Sotera Health Company | 5.43B | 0.69% | 1,946,705 | 1.22B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.40B | -0.77% | 1,093,724 | 1.58B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.22B | - | 909,129 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.89B | -3.63% | 1,507,221 | 1.14B |
| 169 | DYN | Dyne Therapeutics, Inc. | 4.85B | -0.80% | 1,901,754 | - |
| 170 | WAY | Waystar Holding Corp. | 4.81B | 2.20% | 2,301,055 | 1.21B |
| 171 | DOCS | Doximity, Inc. | 4.74B | 6.40% | 5,250,520 | 655.57M |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.69B | -0.87% | 854,212 | - |
| 173 | LFST | LifeStance Health Group, Inc. | 4.67B | -0.08% | 5,043,128 | 1.58B |
| 174 | MANE | Veradermics, Incorporated | 4.64B | 1.79% | 571,758 | - |
| 175 | ICUI | ICU Medical, Inc. | 4.58B | 2.10% | 186,246 | 2.16B |
| 176 | PBLS | Parabilis Medicines, Inc. | 4.54B | -4.65% | 271,010 | - |
| 177 | LIVN | LivaNova PLC | 4.53B | 1.76% | 677,626 | 1.47B |
| 178 | INDV | Indivior Pharmaceuticals, Inc. | 4.51B | -1.32% | 2,337,447 | 1.33B |
| 179 | NVST | Envista Holdings Corporation | 4.51B | -2.19% | 2,654,515 | 2.86B |
| 180 | CON | Concentra Group Holdings Parent, Inc. | 4.48B | 1.68% | 1,660,420 | 2.29B |
| 181 | BLLN | BillionToOne, Inc. | 4.44B | -3.50% | 832,828 | 397.41M |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.37B | -0.70% | 1,797,066 | 10.35M |
| 183 | TNGX | Tango Therapeutics, Inc. | 4.32B | 0.27% | 2,169,487 | 53.81M |
| 184 | ELVN | Enliven Therapeutics, Inc. | 4.25B | 0.24% | 595,094 | - |
| 185 | ITGR | Integer Holdings Corporation | 4.25B | -0.02% | 1,264,974 | 1.84B |
| 186 | CELC | Celcuity Inc. | 4.22B | -5.95% | 1,420,104 | - |
| 187 | HAE | Haemonetics Corporation | 4.11B | -1.05% | 811,855 | 1.35B |
| 188 | IRTC | iRhythm Holdings, Inc. | 4.06B | -1.75% | 534,239 | 825.34M |
| 189 | TLX | Telix Pharmaceuticals Limited | 4.01B | 3.01% | 85,216 | 803.79M |
| 190 | DNLI | Denali Therapeutics Inc. | 3.97B | -1.78% | 1,346,802 | 3.60M |
| 191 | LEGN | Legend Biotech Corporation | 3.92B | -1.84% | 1,975,069 | 1.27B |
| 192 | ADPT | Adaptive Biotechnologies Corporation | 3.90B | -3.13% | 1,537,647 | 308.08M |
| 193 | GPCR | Structure Therapeutics Inc. | 3.90B | 1.47% | 444,163 | - |
| 194 | VKTX | Viking Therapeutics, Inc. | 3.84B | -3.17% | 3,706,928 | - |
| 195 | RCUS | Arcus Biosciences, Inc. | 3.67B | -0.35% | 984,904 | 117.00M |
| 196 | OPCH | Option Care Health, Inc. | 3.61B | 0.96% | 1,887,685 | 5.69B |
| 197 | OGN | Organon & Co. | 3.60B | 0.44% | 2,082,537 | 6.13B |
| 198 | IDYA | IDEAYA Biosciences, Inc. | 3.54B | -0.76% | 466,193 | 234.13M |
| 199 | NHC | National HealthCare Corporation | 3.44B | -0.81% | 106,595 | 1.56B |
| 200 | VCYT | Veracyte, Inc. | 3.42B | -4.66% | 1,455,132 | 561.90M |
| 201 | ABCL | AbCellera Biologics Inc. | 3.36B | 5.89% | 20,132,021 | 66.17M |
| 202 | CLDX | Celldex Therapeutics, Inc. | 3.35B | -5.04% | 670,930 | 158.00K |
| 203 | QURE | uniQure N.V. | 3.26B | 4.28% | 1,130,079 | 18.67M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.25B | -1.71% | 1,585,687 | 463.98M |
| 205 | MBX | MBX Biosciences, Inc. | 3.23B | 0.16% | 334,917 | - |
| 206 | PLSE | Pulse Biosciences, Inc. | 3.20B | 3.69% | 493,638 | 1.19M |
| 207 | WRBY | Warby Parker Inc. | 3.20B | 2.21% | 1,835,522 | 911.61M |
| 208 | NAMS | NewAmsterdam Pharma Company N.V. | 3.19B | -4.17% | 1,225,352 | 7.12M |
| 209 | ALMS | Alumis Inc. | 3.11B | -4.46% | 832,442 | 7.40M |
| 210 | TMDX | TransMedics Group, Inc. | 3.11B | 3.01% | 710,229 | 668.47M |
| 211 | IRON | Disc Medicine, Inc. | 3.07B | -0.72% | 340,964 | - |
| 212 | GRAL | GRAIL, Inc. | 3.05B | -1.02% | 529,392 | 165.26M |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 3.02B | -1.63% | 631,792 | 606.33M |
| 214 | IMNM | Immunome, Inc. | 3.00B | -5.61% | 946,922 | 4.02M |
| 215 | BKD | Brookdale Senior Living Inc. | 3.00B | -3.31% | 5,470,873 | 2.93B |
| 216 | IOVA | Iovance Biotherapeutics, Inc. | 2.95B | -3.26% | 15,679,356 | 324.97M |
| 217 | ZLAB | Zai Lab Limited | 2.92B | 2.12% | 1,042,216 | 449.61M |
| 218 | NRIX | Nurix Therapeutics, Inc. | 2.82B | 2.10% | 1,372,051 | 36.77M |
| 219 | ACHC | Acadia Healthcare Company, Inc. | 2.82B | -4.61% | 1,160,676 | 3.37B |
| 220 | ALHC | Alignment Healthcare, Inc. | 2.79B | -0.44% | 6,220,327 | 4.58B |
| 221 | PRVA | Privia Health Group, Inc. | 2.78B | 1.02% | 1,133,955 | 2.36B |
| 222 | SUPN | Supernus Pharmaceuticals, Inc. | 2.74B | -1.50% | 667,872 | 830.44M |
| 223 | HTFL | HeartFlow, Inc. | 2.70B | 3.89% | 1,938,791 | 212.07M |
| 224 | ATAI | AtaiBeckley Inc. | 2.69B | 0.28% | 4,099,277 | 4.47M |
| 225 | BEAM | Beam Therapeutics Inc. | 2.65B | -0.75% | 2,021,808 | 156.04M |
| 226 | RGC | Regencell Bioscience Holdings Limited | 2.60B | 3.56% | 166,471 | - |
| 227 | RARE | Ultragenyx Pharmaceutical Inc. | 2.59B | -1.79% | 946,128 | 717.00M |
| 228 | NEOG | Neogen Corporation | 2.59B | 3.75% | 1,645,335 | 870.40M |
| 229 | TRVI | Trevi Therapeutics, Inc. | 2.59B | 2.37% | 2,079,803 | - |
| 230 | AXGN | Axogen, Inc. | 2.58B | -3.26% | 760,452 | 251.17M |
| 231 | NKTR | Nektar Therapeutics | 2.57B | -0.14% | 628,205 | 55.63M |
| 232 | COAG | Hemab Therapeutics Holdings, Inc. | 2.52B | 0.88% | 171,433 | - |
| 233 | KOD | Kodiak Sciences Inc. | 2.51B | -7.90% | 815,010 | - |
| 234 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.51B | -7.37% | 4,583,164 | 940.61M |
| 235 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.50B | -3.73% | 839,453 | -665.00K |
| 236 | SLS | SELLAS Life Sciences Group, Inc. | 2.50B | 5.01% | 5,671,915 | - |
| 237 | VRDN | Viridian Therapeutics, Inc. | 2.49B | -3.89% | 1,767,879 | 71.13M |
| 238 | UFPT | UFP Technologies, Inc. | 2.48B | -0.81% | 223,418 | 631.64M |
| 239 | AVAH | Aveanna Healthcare Holdings Inc. | 2.46B | 24.75% | 10,117,526 | 2.60B |
| 240 | CDNA | CareDx, Inc. | 2.45B | 0.15% | 739,265 | 458.09M |
| 241 | GRDN | Guardian Pharmacy Services, Inc. | 2.44B | -0.31% | 310,918 | 1.46B |
| 242 | PBH | Prestige Consumer Healthcare Inc. | 2.43B | -1.82% | 643,822 | 1.10B |
| 243 | PHVS | Pharvaris N.V. | 2.39B | -6.64% | 738,225 | - |
| 244 | CLOV | Clover Health Investments, Corp. | 2.38B | -1.10% | 3,274,448 | 2.48B |
| 245 | BHC | Bausch Health Companies Inc. | 2.37B | 2.09% | 1,820,722 | 10.85B |
| 246 | WGS | GeneDx Holdings Corp. | 2.36B | -3.93% | 715,121 | 454.43M |
| 247 | BFLY | Butterfly Network, Inc. | 2.36B | -6.24% | 6,905,198 | 112.14M |
| 248 | URGN | UroGen Pharma Ltd. | 2.35B | -1.80% | 859,984 | 188.73M |
| 249 | KLRA | Kailera Therapeutics, Inc. | 2.33B | -3.34% | 453,828 | - |
| 250 | PGEN | Precigen, Inc. | 2.32B | -5.26% | 5,532,834 | 85.72M |
| 251 | XRAY | DENTSPLY SIRONA Inc. | 2.31B | 1.49% | 3,297,570 | 3.64B |
| 252 | MLYS | Mineralys Therapeutics, Inc. | 2.31B | -3.55% | 863,226 | - |
| 253 | ALMR | Alamar Biosciences, Inc. | 2.28B | -0.60% | 373,566 | 100.42M |
| 254 | VCEL | Vericel Corporation | 2.28B | -0.42% | 527,894 | 306.30M |
| 255 | RAPP | Rapport Therapeutics, Inc. | 2.27B | -0.78% | 242,096 | 20.00M |
| 256 | PVLA | Palvella Therapeutics, Inc. | 2.26B | 0.95% | 243,210 | - |
| 257 | ESTA | Establishment Labs Holdings Inc. | 2.25B | 0.01% | 563,370 | 245.82M |
| 258 | BHVN | Biohaven Ltd. | 2.24B | 3.20% | 1,651,870 | - |
| 259 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | -3.19% | 582,635 | 959.90M |
| 260 | HCM | HUTCHMED (China) Limited | 2.23B | -0.73% | 77,119 | 549.12M |
| 261 | OCUL | Ocular Therapeutix, Inc. | 2.22B | -1.27% | 2,584,840 | 52.06M |
| 262 | ATRC | AtriCure, Inc. | 2.21B | -0.16% | 549,783 | 569.62M |
| 263 | ADUS | Addus HomeCare Corporation | 2.15B | -0.40% | 176,778 | 1.48B |
| 264 | NUVB | Nuvation Bio Inc. | 2.14B | -4.98% | 5,229,725 | 169.90M |
| 265 | ADMA | ADMA Biologics, Inc. | 2.11B | -3.78% | 3,107,174 | 512.28M |
| 266 | SEPN | Septerna, Inc. | 2.11B | -6.33% | 877,879 | 98.88M |
| 267 | NEO | NeoGenomics, Inc. | 2.11B | -0.18% | 956,240 | 766.30M |
| 268 | MD | Pediatrix Medical Group, Inc. | 2.09B | -0.49% | 719,453 | 1.95B |
| 269 | VERA | Vera Therapeutics, Inc. | 2.08B | -3.67% | 1,167,738 | - |
| 270 | KARD | Kardigan, Inc. | 2.04B | 0.14% | 216,757 | - |
| 271 | MESO | Mesoblast Limited | 2.03B | -1.73% | 139,839 | 65.38M |
| 272 | NVCR | NovoCure Limited | 2.02B | -1.19% | 637,127 | 699.19M |
| 273 | STOK | Stoke Therapeutics, Inc. | 2.02B | -5.03% | 480,972 | 27.59M |
| 274 | AUPH | Aurinia Pharmaceuticals Inc. | 2.02B | -1.75% | 1,594,161 | 311.51M |
| 275 | AGIO | Agios Pharmaceuticals, Inc. | 2.00B | -2.16% | 939,123 | 98.34M |
| 276 | PGNY | Progyny, Inc. | 1.99B | 1.85% | 1,134,004 | 1.31B |
| 277 | SGRY | Surgery Partners, Inc. | 1.97B | -0.85% | 2,243,721 | 3.37B |
| 278 | TSHA | Taysha Gene Therapies, Inc. | 1.95B | -6.55% | 2,184,695 | 5.49M |
| 279 | SRPT | Sarepta Therapeutics, Inc. | 1.95B | 0.22% | 2,518,301 | 1.97B |
| 280 | NBTX | Nanobiotix S.A. | 1.94B | -3.22% | 107,008 | 38.27M |
| 281 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.10% | 1,150,595 | - |
| 282 | GHRS | GH Research PLC | 1.94B | -6.78% | 352,264 | - |
| 283 | ASTH | Astrana Health, Inc. | 1.93B | 5.59% | 352,413 | 3.84B |
| 284 | GENB | Generate Biomedicines, Inc. | 1.93B | -0.40% | 503,577 | 26.48M |
| 285 | ZBIO | Zenas BioPharma, Inc. | 1.90B | -6.68% | 881,512 | 1.00M |
| 286 | DMRA | Damora Therapeutics, Inc. | 1.90B | -0.87% | 227,792 | - |
| 287 | LMAT | LeMaitre Vascular, Inc. | 1.87B | -0.24% | 304,065 | 262.43M |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.86B | 0.46% | 354,247 | 481.07M |
| 289 | TRLV | Trulieve Cannabis Corp. | 1.85B | 5.38% | 1,139,545 | 1.14B |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.85B | 0.39% | 379,801 | 1.13B |
| 291 | CMPS | COMPASS Pathways plc | 1.84B | -6.54% | 2,387,060 | - |
| 292 | ZYME | Zymeworks Inc. | 1.83B | 3.33% | 664,683 | 37.13M |
| 293 | PRGO | Perrigo Company plc | 1.78B | 1.10% | 2,528,602 | 4.14B |
| 294 | RXRX | Recursion Pharmaceuticals, Inc. | 1.78B | 0.61% | 10,699,989 | 54.86M |
| 295 | IMCR | Immunocore Holdings plc | 1.76B | -1.55% | 329,516 | 430.78M |
| 296 | AAPG | Ascentage Pharma Group International | 1.74B | 0.16% | 2,981 | 82.08M |
| 297 | BLFS | BioLife Solutions, Inc. | 1.72B | 0.74% | 592,528 | 106.69M |
| 298 | OMCL | Omnicell, Inc. | 1.72B | 1.37% | 660,203 | 1.25B |
| 299 | XNCR | Xencor, Inc. | 1.71B | -0.82% | 975,295 | 104.97M |
| 300 | SNDX | Syndax Pharmaceuticals, Inc. | 1.70B | -3.64% | 1,195,108 | 252.25M |
| 301 | FTRE | Fortrea Holdings Inc. | 1.69B | -2.78% | 1,329,591 | 2.68B |
| 302 | INSP | Inspire Medical Systems, Inc. | 1.68B | -0.14% | 485,923 | 898.74M |
| 303 | BRVE | Braveheart Bio, Inc. | 1.67B | -0.69% | 707,662 | - |
| 304 | ANAB | AnaptysBio, Inc. | 1.66B | -1.68% | 270,913 | 232.39M |
| 305 | NTLA | Intellia Therapeutics, Inc. | 1.66B | -2.15% | 2,945,751 | 59.51M |
| 306 | KMTS | Kestra Medical Technologies, Ltd. | 1.63B | -0.93% | 347,939 | 95.13M |
| 307 | ABSI | Absci Corporation | 1.62B | -0.42% | 2,553,150 | 1.56M |
| 308 | AVLN | Avalyn Pharma Inc. | 1.62B | -2.14% | 266,310 | - |
| 309 | TNDM | Tandem Diabetes Care, Inc. | 1.61B | -1.32% | 1,420,046 | 1.04B |
| 310 | ANIP | ANI Pharmaceuticals, Inc. | 1.60B | -0.47% | 330,213 | 978.38M |
| 311 | TRAX | First Tracks Biotherapeutics, Inc. | 1.57B | -4.55% | 715,085 | - |
| 312 | BCAX | Bicara Therapeutics Inc. | 1.56B | -4.06% | 751,522 | - |
| 313 | ARDT | Ardent Health, Inc. | 1.55B | -0.72% | 244,823 | 6.41B |
| 314 | PSNL | Personalis, Inc. | 1.54B | 1.48% | 1,168,974 | 69.67M |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.54B | 0.49% | 383,349 | 20.00M |
| 316 | VIR | Vir Biotechnology, Inc. | 1.52B | 0.45% | 1,246,431 | 303.23M |
| 317 | XERS | Xeris Biopharma Holdings, Inc. | 1.52B | -1.88% | 1,851,681 | 335.41M |
| 318 | JBIO | Jade Biosciences, Inc. | 1.51B | 2.59% | 1,089,592 | - |
| 319 | ATEC | Alphatec Holdings, Inc. | 1.51B | 1.25% | 1,192,154 | 815.05M |
| 320 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.50B | - | 1,407,285 | 208.78M |
| 321 | INVA | Innoviva, Inc. | 1.50B | -0.29% | 527,238 | 440.00M |
| 322 | TYRA | Tyra Biosciences, Inc. | 1.49B | -1.11% | 528,378 | - |
| 323 | AGL | agilon health, inc. | 1.49B | 3.06% | 231,551 | 5.92B |
| 324 | CNMD | CONMED Corporation | 1.49B | 0.69% | 219,951 | 1.37B |
| 325 | OMDA | Omada Health, Inc. | 1.49B | 2.22% | 1,408,266 | 309.76M |
| 326 | AZTA | Azenta, Inc. | 1.49B | 1.13% | 450,694 | 613.81M |
| 327 | ENOV | Enovis Corporation | 1.48B | 3.93% | 1,018,448 | 2.30B |
| 328 | AVBP | ArriVent BioPharma, Inc. | 1.48B | -4.64% | 478,873 | - |
| 329 | ALVO | Alvotech | 1.46B | 2.00% | 559,858 | 562.04M |
| 330 | HROW | Harrow, Inc. | 1.46B | -1.24% | 516,472 | 275.59M |
| 331 | HCSG | Healthcare Services Group, Inc. | 1.45B | 1.39% | 708,530 | 1.86B |
| 332 | INNV | InnovAge Holding Corp. | 1.45B | 2.11% | 117,659 | 949.17M |
| 333 | LBRX | LB Pharmaceuticals Inc | 1.43B | -2.45% | 432,903 | - |
| 334 | REPL | Replimune Group, Inc. | 1.42B | -0.33% | 3,220,713 | - |
| 335 | INBX | Inhibrx Biosciences, Inc. | 1.42B | -1.37% | 251,198 | 1.30M |
| 336 | ORIC | ORIC Pharmaceuticals, Inc. | 1.42B | -0.22% | 1,047,797 | - |
| 337 | IART | Integra LifeSciences Holdings Corporation | 1.42B | 4.95% | 795,113 | 1.65B |
| 338 | MLTX | MoonLake Immunotherapeutics | 1.40B | -4.24% | 1,337,742 | - |
| 339 | AORT | Artivion, Inc. | 1.39B | -0.80% | 774,602 | 471.47M |
| 340 | PAHC | Phibro Animal Health Corporation | 1.38B | 0.77% | 128,887 | 1.50B |
| 341 | SDGR | Schrödinger, Inc. | 1.38B | -0.91% | 920,934 | 259.04M |
| 342 | VOR | Vor Biopharma Inc. | 1.38B | 4.25% | 933,744 | - |
| 343 | GLUE | Monte Rosa Therapeutics, Inc. | 1.35B | -0.69% | 682,350 | 28.73M |
| 344 | PNTG | The Pennant Group, Inc. | 1.35B | 0.68% | 236,666 | 1.10B |
| 345 | NVAX | Novavax, Inc. | 1.34B | 2.26% | 3,506,534 | 413.80M |
| 346 | SVRA | Savara Inc. | 1.34B | -7.54% | 1,874,365 | - |
| 347 | DRTS | Alpha Tau Medical Ltd. | 1.34B | 4.54% | 886,285 | - |
| 348 | AMN | AMN Healthcare Services, Inc. | 1.34B | 6.32% | 607,436 | 3.43B |
| 349 | AKTS | Aktis Oncology, Inc. | 1.32B | -0.88% | 156,314 | 10.06M |
| 350 | IMTX | Immatics N.V. | 1.31B | -1.24% | 284,200 | 43.00M |
| 351 | FRNM | Freenome, Inc. | 1.31B | 0.52% | 611,514 | 34.24M |
| 352 | NUTX | Nutex Health Inc. | 1.28B | 8.33% | 189,834 | 846.72M |
| 353 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | 0.60% | 1,007,120 | - |
| 354 | STAA | STAAR Surgical Company | 1.27B | -0.31% | 1,864,616 | 339.59M |
| 355 | SPTX | Seaport Therapeutics, Inc. | 1.27B | -0.38% | 121,799 | - |
| 356 | GDRX | GoodRx Holdings, Inc. | 1.27B | 3.62% | 1,208,958 | 785.23M |
| 357 | LTGO | Latigo Biotherapeutics, Inc. | 1.27B | 3.51% | 273,539 | - |
| 358 | ANRO | Alto Neuroscience, Inc. | 1.27B | 10.69% | 989,977 | - |
| 359 | TDOC | Teladoc Health, Inc. | 1.26B | 3.73% | 3,754,465 | 2.49B |
| 360 | CGEM | Cullinan Therapeutics, Inc. | 1.26B | 0.20% | 1,802,497 | - |
| 361 | PRCT | PROCEPT BioRobotics Corporation | 1.26B | 3.29% | 1,239,106 | 337.34M |
| 362 | OMER | Omeros Corporation | 1.26B | 26.55% | 13,436,013 | 38.42M |
| 363 | CERT | Certara, Inc. | 1.24B | 1.75% | 5,416,732 | 421.75M |
| 364 | USPH | U.S. Physical Therapy, Inc. | 1.24B | 0.99% | 176,683 | 804.27M |
| 365 | MNKD | MannKind Corporation | 1.20B | -3.12% | 5,239,893 | 393.63M |
| 366 | MGTX | MeiraGTx Holdings plc | 1.17B | -2.24% | 795,631 | 397.50M |
| 367 | LMRI | Lumexa Imaging Holdings, Inc. | 1.17B | 4.01% | 1,140,919 | 1.04B |
| 368 | BVS | Bioventus Inc. | 1.17B | -0.22% | 632,608 | 581.85M |
| 369 | ETON | Eton Pharmaceuticals, Inc. | 1.17B | -1.88% | 696,938 | 105.60M |
| 370 | CRON | Cronos Group Inc. | 1.17B | -0.32% | 1,514,852 | 179.09M |
| 371 | EYPT | EyePoint, Inc. | 1.16B | -0.37% | 1,202,186 | 2.79M |
| 372 | APMD | Apnimed, Inc. | 1.15B | 8.03% | 775,200 | 120.15M |
| 373 | IRMD | IRADIMED CORPORATION | 1.11B | -0.27% | 90,088 | 86.34M |
| 374 | AHG | Akso Health Group | 1.11B | -11.56% | 6,269 | 13.83M |
| 375 | SANA | Sana Biotechnology, Inc. | 1.10B | -2.65% | 1,966,555 | - |
| 376 | IVA | Inventiva S.A. | 1.10B | -1.71% | 514,766 | 7.94M |
| 377 | GMRS | GMR Solutions Inc. | 1.08B | 8.55% | 3,269,958 | 5.88B |
| 378 | OPK | OPKO Health, Inc. | 1.04B | 0.72% | 1,618,343 | 587.90M |
| 379 | AVTX | Avalo Therapeutics, Inc. | 1.04B | -0.51% | 391,152 | 59.00K |
| 380 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.04B | -0.43% | 2,315,188 | 41.47M |
| 381 | QDEL | QuidelOrtho Corporation | 1.03B | 1.75% | 1,446,396 | 2.67B |
| 382 | WVE | Wave Life Sciences Ltd. | 1.02B | -0.76% | 6,064,866 | 65.37M |
| 383 | ANNX | Annexon, Inc. | 997.19M | -1.31% | 3,122,829 | - |
| 384 | ODTX | Odyssey Therapeutics, Inc. | 992.87M | -3.99% | 113,197 | 99.00K |
| 385 | GERN | Geron Corporation | 986.20M | -2.23% | 5,633,568 | 204.56M |
| 386 | JANX | Janux Therapeutics, Inc. | 978.19M | -4.02% | 847,450 | 24.00M |
| 387 | ARDX | Ardelyx, Inc. | 974.32M | -1.51% | 4,354,766 | 450.89M |
| 388 | SLDB | Solid Biosciences Inc. | 973.61M | 0.11% | 828,257 | - |
| 389 | CSTL | Castle Biosciences, Inc. | 933.29M | -2.80% | 362,229 | 357.28M |
| 390 | PCRX | Pacira BioSciences, Inc. | 924.00M | -2.19% | 806,769 | 746.16M |
| 391 | OLMA | Olema Pharmaceuticals, Inc. | 919.60M | 0.67% | 1,152,061 | - |
| 392 | COLL | Collegium Pharmaceutical, Inc. | 916.44M | 9.53% | 1,558,477 | 808.21M |
| 393 | ABUS | Arbutus Biopharma Corporation | 906.14M | -0.22% | 1,390,162 | 181.72M |
| 394 | DSGN | Design Therapeutics, Inc. | 900.55M | -1.84% | 406,836 | - |
| 395 | KURA | Kura Oncology, Inc. | 897.61M | 1.51% | 4,478,080 | 77.23M |
| 396 | GLAS | Glass House Brands Inc. | 894.13M | -3.11% | 383,031 | 177.68M |
| 397 | CBLL | CeriBell, Inc. | 892.29M | 1.48% | 510,444 | 101.96M |
| 398 | TBPH | Theravance Biopharma, Inc. | 878.47M | - | 357,999 | 104.31M |
| 399 | INMD | InMode Ltd. | 873.71M | -0.20% | 347,695 | 374.63M |
| 400 | TALK | Talkspace, Inc. | 870.58M | 0.19% | 1,216,693 | 245.73M |
| 401 | AVR | Anteris Technologies Global Corp. | 870.28M | 0.68% | 446,995 | 2.24M |
| 402 | CADL | Candel Therapeutics, Inc. | 864.59M | 10.49% | 2,152,443 | - |
| 403 | ACRS | Aclaris Therapeutics, Inc. | 862.59M | 0.34% | 1,065,838 | 8.22M |
| 404 | AMPH | Amphastar Pharmaceuticals, Inc. | 858.42M | 1.00% | 526,117 | 730.02M |
| 405 | SIBN | SI-BONE, Inc. | 849.31M | -0.26% | 246,715 | 213.60M |
| 406 | HSTM | HealthStream, Inc. | 848.54M | 2.33% | 179,545 | 321.12M |
| 407 | CLYM | Climb Bio, Inc. | 846.04M | 2.36% | 1,580,548 | - |
| 408 | SGP | SpyGlass Pharma, Inc. | 841.89M | -0.40% | 77,532 | - |
| 409 | SLN | Silence Therapeutics plc | 841.12M | 2.87% | 2,814,361 | 615.00K |
| 410 | PHAR | Pharming Group N.V. | 839.41M | 4.40% | 32,811 | 366.48M |
| 411 | ATTO | Attovia Therapeutics, Inc. | 825.30M | 6.20% | 406,528 | 1.35M |
| 412 | OBX | Obsidian Therapeutics, Inc. | 819.73M | -32.43% | 163,709 | - |
| 413 | DBVT | DBV Technologies S.A. | 814.55M | -0.78% | 283,580 | 5.04M |
| 414 | BBNX | Beta Bionics, Inc. | 813.41M | 4.33% | 1,503,336 | 119.01M |
| 415 | AURA | Aura Biosciences, Inc. | 793.34M | -1.29% | 1,053,942 | - |
| 416 | OCS | Oculis Holding AG | 791.41M | -0.54% | 193,266 | 1.45M |
| 417 | IMMX | Immix Biopharma, Inc. | 781.21M | -3.96% | 1,141,510 | - |
| 418 | PHR | Phreesia, Inc. | 780.07M | 2.94% | 491,558 | 495.59M |
| 419 | VREX | Varex Imaging Corporation | 779.74M | 0.27% | 1,059,585 | 865.00M |
| 420 | DRUG | Bright Minds Biosciences Inc. | 772.26M | -1.73% | 78,270 | - |
| 421 | SSII | SS Innovations International, Inc. | 766.50M | 3.79% | 48,049 | 52.40M |
| 422 | RIGL | Rigel Pharmaceuticals, Inc. | 761.95M | -2.58% | 265,330 | 276.79M |
| 423 | AHCO | AdaptHealth Corp. | 760.43M | -1.21% | 2,512,828 | 3.36B |
| 424 | ACHV | Achieve Life Sciences, Inc. | 746.04M | 8.37% | 2,767,844 | - |
| 425 | MNPR | Monopar Therapeutics Inc. | 741.09M | -3.91% | 162,522 | - |
| 426 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 739.39M | -2.02% | 303,827 | - |
| 427 | FTH | Faeth Therapeutics, Inc. | 737.74M | -2.83% | 192,485 | - |
| 428 | STTK | Shattuck Labs, Inc. | 734.66M | -2.27% | 678,021 | 1.00M |
| 429 | CTMX | CytomX Therapeutics, Inc. | 729.96M | -4.01% | 1,808,732 | 18.30M |
| 430 | PHAT | Phathom Pharmaceuticals, Inc. | 729.17M | 0.11% | 1,205,706 | 239.66M |
| 431 | EVO | Evotec SE | 727.57M | -7.76% | 28,457 | 819.47M |
| 432 | CTEV | Claritev Corporation | 715.52M | 19.54% | 223,361 | 994.67M |
| 433 | NGNE | Neurogene Inc. | 713.01M | -3.65% | 140,295 | 925.00K |
| 434 | CBIO | Crescent Biopharma, Inc. | 711.78M | 1.22% | 120,451 | 11.88M |
| 435 | HELP | Cybin Inc. | 709.72M | -0.35% | 1,940,081 | - |
| 436 | RGNX | REGENXBIO Inc. | 703.70M | -2.29% | 805,581 | 174.48M |
| 437 | GYRE | Gyre Therapeutics, Inc. | 693.46M | -1.80% | 48,969 | 109.82M |
| 438 | AGMB | AgomAb Therapeutics NV | 686.76M | -1.17% | 241,580 | - |
| 439 | ALLO | Allogene Therapeutics, Inc. | 684.07M | -4.35% | 6,335,871 | 4.64M |
| 440 | BWAY | BrainsWay Ltd. | 676.96M | -0.78% | 230,235 | 56.22M |
| 441 | IRWD | Ironwood Pharmaceuticals, Inc. | 674.18M | -5.56% | 2,084,203 | 389.32M |
| 442 | TECX | Tectonic Therapeutic, Inc. | 664.29M | -7.74% | 277,754 | - |
| 443 | ZVRA | Zevra Therapeutics, Inc. | 663.91M | -2.27% | 807,987 | 136.07M |
| 444 | KIDS | OrthoPediatrics Corp. | 653.01M | 0.60% | 205,631 | 252.72M |
| 445 | SOPH | SOPHiA GENETICS SA | 648.67M | 0.66% | 325,878 | 86.17M |
| 446 | ANGO | AngioDynamics, Inc. | 647.27M | -0.57% | 409,429 | 320.17M |
| 447 | FDMT | 4D Molecular Therapeutics, Inc. | 643.60M | -1.85% | 707,434 | 92.01M |
| 448 | STLN | Starling Oncology, Inc. | 637.99M | -0.95% | 1,074,291 | 587.24M |
| 449 | TLRY | Tilray Brands, Inc. | 637.39M | 0.43% | 2,859,059 | 915.45M |
| 450 | CTKB | Cytek Biosciences, Inc. | 635.62M | 2.30% | 1,022,956 | 206.71M |
| 451 | CRMD | CorMedix Inc. | 634.47M | 14.65% | 6,069,943 | 462.25M |
| 452 | NVCT | Nuvectis Pharma, Inc. | 626.54M | -1.59% | 144,237 | - |
| 453 | MDXG | MiMedx Group, Inc. | 612.19M | -1.87% | 1,067,842 | 355.17M |
| 454 | SPRY | ARS Pharmaceuticals, Inc. | 605.75M | 0.83% | 1,978,723 | 98.99M |
| 455 | VSTM | Verastem, Inc. | 604.06M | -4.03% | 1,856,898 | 87.53M |
| 456 | DCTH | Delcath Systems, Inc. | 602.37M | 1.46% | 815,048 | 95.42M |
| 457 | AUTL | Autolus Therapeutics plc | 590.84M | 4.72% | 2,242,457 | 117.39M |
| 458 | ARVN | Arvinas, Inc. | 589.13M | 1.58% | 939,144 | 316.70M |
| 459 | SGMT | Sagimet Biosciences Inc. | 576.83M | -1.17% | 966,107 | - |
| 460 | ASMB | Assembly Biosciences, Inc. | 576.57M | 10.68% | 729,236 | 74.85M |
| 461 | CTNM | Contineum Therapeutics, Inc. | 575.60M | 2.14% | 401,707 | - |
| 462 | CERS | Cerus Corporation | 572.33M | 4.80% | 2,810,990 | 221.55M |
| 463 | PRME | Prime Medicine, Inc. | 563.96M | -0.94% | 1,888,902 | 4.07M |
| 464 | ALT | Altimmune, Inc. | 560.21M | -1.71% | 4,108,986 | 31.00K |
| 465 | EIKN | Eikon Therapeutics, Inc. | 559.25M | -0.86% | 370,339 | - |
| 466 | ARTV | Artiva Biotherapeutics, Inc. | 552.46M | -1.99% | 253,287 | 251.00K |
| 467 | PRLD | Prelude Therapeutics Incorporated | 552.05M | -6.46% | 888,274 | 22.42M |
| 468 | OVID | Ovid Therapeutics Inc. | 546.83M | 6.87% | 2,243,221 | 1.58M |
| 469 | ZURA | Zura Bio Limited | 539.52M | -2.60% | 834,832 | - |
| 470 | VALN | Valneva SE | 537.13M | 1.80% | 29,384 | 163.30M |
| 471 | TCMD | Tactile Systems Technology, Inc. | 537.09M | -3.26% | 507,486 | 350.31M |
| 472 | AQST | Aquestive Therapeutics, Inc. | 533.42M | 0.47% | 3,745,395 | 54.09M |
| 473 | EOLS | Evolus, Inc. | 529.72M | -1.23% | 778,375 | 316.49M |
| 474 | SRTA | Strata Critical Medical, Inc. | 528.15M | -1.00% | 688,570 | 255.98M |
| 475 | EVH | Evolent Health, Inc. | 526.86M | 11.75% | 3,732,253 | 2.10B |
| 476 | MPLT | MapLight Therapeutics, Inc. | 525.10M | 1.76% | 501,343 | - |
| 477 | ANL | Adlai Nortye Ltd. | 514.40M | -1.76% | 78,575 | 5.00M |
| 478 | FLGT | Fulgent Genetics, Inc. | 513.16M | -0.32% | 139,689 | 323.93M |
| 479 | EVMN | Evommune, Inc. | 510.63M | -0.35% | 345,219 | 10.00M |
| 480 | RLMD | Relmada Therapeutics, Inc. | 506.68M | 0.64% | 1,250,294 | - |
| 481 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 4.81M |
| 482 | CCCC | C4 Therapeutics, Inc. | 501.94M | 4.62% | 3,726,050 | 35.04M |
| 483 | BLSM | BlossomHill Therapeutics, Inc. | 501.02M | 0.68% | 425,883 | - |
| 484 | KYTX | Kyverna Therapeutics, Inc. | 499.70M | 0.37% | 739,872 | - |
| 485 | OABI | OmniAb, Inc. | 498.69M | 0.29% | 922,411 | 38.46M |
| 486 | NPCE | NeuroPace, Inc. | 498.05M | -0.34% | 112,792 | 106.99M |
| 487 | ENTX | Entera Bio Ltd. | 496.92M | 2.50% | 246,482 | 42.00K |
| 488 | DNA | Ginkgo Bioworks Holdings, Inc. | 487.54M | 0.42% | 1,118,587 | 132.42M |
| 489 | RZLT | Rezolute, Inc. | 480.55M | -2.13% | 800,613 | - |
| 490 | BIOA | BioAge Labs, Inc. | 478.70M | -0.48% | 536,932 | 10.36M |
| 491 | NRC | NRC Health | 471.37M | 3.40% | 110,555 | 140.00M |
| 492 | CLPT | ClearPoint Neuro, Inc. | 470.38M | 1.58% | 319,244 | 42.28M |
| 493 | PRTA | Prothena Corporation plc | 466.14M | -1.94% | 343,057 | 54.53M |
| 494 | CABA | Cabaletta Bio, Inc. | 459.47M | -4.91% | 3,099,458 | - |
| 495 | SGHT | Sight Sciences, Inc. | 458.33M | 0.48% | 306,751 | 83.38M |
| 496 | OCGN | Ocugen, Inc. | 457.80M | -3.57% | 3,921,560 | 4.58M |
| 497 | QTTB | Q32 Bio Inc. | 457.56M | - | 182,377 | 53.74M |
| 498 | NNNN | Anbio Biotechnology | 450.32M | 3.74% | 41,582 | 8.65M |
| 499 | PBYI | Puma Biotechnology, Inc. | 449.61M | -2.13% | 263,053 | 231.24M |
| 500 | LRMR | Larimar Therapeutics, Inc. | 445.72M | -2.29% | 1,502,798 | - |